| Rank | Ticker | Exchange | Price | Market Cap | 52W High | 52W Low | Analyst Rating |
|---|---|---|---|---|---|---|---|
#1 | COST | Nasdaq | $880.36 | $431.1B | $1,078.24 | $871.09 | Buy |
#2 | PG | Nasdaq | $141.13 | $351.4B | $179.99 | $138.14 | Buy |
#3 | TMUS | Nasdaq | $195.53 | $236.3B | $276.49 | $194.89 | Buy |
#4 | MDLZ | Nasdaq | $53.86 | $78.9B | $71.15 | $53.13 | Buy |
#5 | ZTS | Nasdaq | $118.06 | $66.2B | $181.85 | $115.25 | Buy |
#6 | MSI | Nasdaq | $369.42 | $61.3B | $492.22 | $365.40 | Buy |
#7 | ROP | Nasdaq | $447.67 | $48.4B | $595.17 | $435.42 | Buy |
#8 | LNG | Nasdaq | $192.71 | $46.4B | $257.65 | $188.70 | Strong Buy |
#9 | VICI | Nasdaq | $28.01 | $32.4B | $34.03 | $27.63 | Buy |
#10 | TTD | Nasdaq | $37.07 | $21.2B | $137.03 | $38.23 | Buy |
#11 | NTNX | Nasdaq | $47.25 | $20.5B | $83.36 | $46.12 | Buy |
#12 | TYL | Nasdaq | $456.13 | $20.2B | $661.31 | $450.00 | Buy |
#13 | CHD | Nasdaq | $83.60 | $19.8B | $116.46 | $81.33 | Buy |
#14 | INVH | Nasdaq | $26.65 | $16.0B | $35.80 | $26.02 | Buy |
#15 | GLPI | Nasdaq | $42.05 | $12.6B | $52.25 | $41.17 | Buy |
#16 | DOCS | Nasdaq | $44.68 | $12.3B | $85.21 | $44.71 | Buy |
#17 | FCPT | Nasdaq | $23.20 | $2.5B | $29.81 | $22.80 | Buy |
The FinQuota filters have identified what they believe to be the "NASDAQ 52 Week Low Stocks (December 11, 2025) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.